|
MRPL35 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.661500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.871900E-02 |
| Normal-vs-Stage2 |
5.845000E-01 |
| Normal-vs-Stage3 |
3.933700E-02 |
| Normal-vs-Stage4 |
3.678000E-02 |
| Stage1-vs-Stage2 |
8.311600E-01 |
| Stage1-vs-Stage3 |
3.433600E-01 |
| Stage1-vs-Stage4 |
1.159640E-01 |
| Stage2-vs-Stage3 |
3.885600E-01 |
| Stage2-vs-Stage4 |
1.662020E-01 |
| Stage3-vs-Stage4 |
3.414800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.582100E-02 |
| Normal-vs-AfricanAmerican |
3.480300E-02 |
| Normal-vs-Asian |
4.675200E-01 |
| Caucasian-vs-AfricanAmerican |
5.491200E-01 |
| Caucasian-vs-Asian |
8.637200E-01 |
| AfricanAmerican-vs-Asian |
9.693600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.982400E-03 |
| Normal-vs-Female |
1.564010E-01 |
| Male-vs-Female |
6.340800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.822990E-03 |
| Normal-vs-Extreme_Weight |
1.057910E-02 |
| Normal-vs-Obese |
7.455600E-02 |
| Normal-vs-Extreme_Obese |
3.683200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.383200E-01 |
| Normal_Weight-vs-Obese |
1.989190E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.044030E-01 |
| Extreme_Weight-vs-Obese |
7.498600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.738620E-01 |
| Obese-vs-Extreme_Obese |
2.015200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.712200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.556500E-02 |
| Normal-vs-Age(61-80Yrs) |
3.469800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.563600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.497800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.555200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.276400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.038800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.931820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.954000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.674200E-02 |
| Normal-VS-Type2 PRCC |
2.540200E-02 |
| Normal-VS-KIRP CIMP |
3.919300E-03 |
| Normal-VS-Unclassified PRCC |
4.930200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.623800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.605730E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.713200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.193150E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.145000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.278300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.218100E-02 |
| Normal-vs-N1 |
3.120300E-03 |
| Normal-vs-N2 |
1.60449999953016E-07 |
| N0-vs-N1 |
5.994400E-01 |
| N0-vs-N2 |
3.078100E-02 |
| N1-vs-N2 |
1.656140E-02 |
|
|
